,ONTOLOGY,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0099566,BP,GO:0099566,regulation of postsynaptic cytosolic calcium ion concentration,2月20日,10/18800,4.81E-05,0.002193911,0.00102878,FZD9/ITPR1,2
GO:1990034,BP,GO:1990034,calcium ion export across plasma membrane,2月20日,10/18800,4.81E-05,0.002193911,0.00102878,YWHAE/ATP2B3,2
GO:0010959,BP,GO:0010959,regulation of metal ion transport,5月20日,403/18800,5.25E-05,0.002321505,0.001088612,TSPO/YWHAE/ATP1B1/GPER1/ATF4,5
GO:0042246,BP,GO:0042246,tissue regeneration,3月20日,72/18800,5.86E-05,0.002517899,0.001180706,PPP3CA/FZD9/NOTCH1,3
GO:0140115,BP,GO:0140115,export across plasma membrane,3月20日,74/18800,6.36E-05,0.002564842,0.001202719,YWHAE/ATP1B1/ATP2B3,3
GO:0001503,BP,GO:0001503,ossification,5月20日,420/18800,6.39E-05,0.002564842,0.001202719,FZD9/SNX10/PTH1R/NOTCH1/ATF4,5
GO:0008016,BP,GO:0008016,regulation of heart contraction,4月20日,211/18800,6.49E-05,0.002564842,0.001202719,YWHAE/ATP1B1/ATP2B3/ATP2A2,4
GO:0032957,BP,GO:0032957,inositol trisphosphate metabolic process,2月20日,12/18800,7.05E-05,0.002564842,0.001202719,ITPKB/GPER1,2
GO:0050804,BP,GO:0050804,modulation of chemical synaptic transmission,5月20日,429/18800,7.06E-05,0.002564842,0.001202719,PPP3CB/PPP3CA/GPER1/ATP2A2/ATF4,5
GO:0099177,BP,GO:0099177,regulation of trans-synaptic signaling,5月20日,430/18800,7.14E-05,0.002564842,0.001202719,PPP3CB/PPP3CA/GPER1/ATP2A2/ATF4,5
GO:0086001,BP,GO:0086001,cardiac muscle cell action potential,3月20日,77/18800,7.16E-05,0.002564842,0.001202719,YWHAE/ATP1B1/ATP2A2,3
GO:0060253,BP,GO:0060253,negative regulation of glial cell proliferation,2月20日,13/18800,8.33E-05,0.002912829,0.001365898,TSPO/NOTCH1,2
GO:0003012,BP,GO:0003012,muscle system process,5月20日,449/18800,8.76E-05,0.002993494,0.001403724,PPP3CA/ATP1B1/GPER1/ATP2A2/NOTCH1,5
GO:0014733,BP,GO:0014733,regulation of skeletal muscle adaptation,2月20日,14/18800,9.71E-05,0.003174645,0.00148867,PPP3CA/ATP2A2,2
GO:0060732,BP,GO:0060732,positive regulation of inositol phosphate biosynthetic process,2月20日,14/18800,9.71E-05,0.003174645,0.00148867,GPER1/PTH1R,2
GO:0060047,BP,GO:0060047,heart contraction,4月20日,247/18800,0.000119389,0.003820433,0.001791496,YWHAE/ATP1B1/ATP2B3/ATP2A2,4
GO:0051924,BP,GO:0051924,regulation of calcium ion transport,4月20日,251/18800,0.000127014,0.003925025,0.001840542,TSPO/YWHAE/ATP1B1/GPER1,4
GO:0010919,BP,GO:0010919,regulation of inositol phosphate biosynthetic process,2月20日,16/18800,0.000127876,0.003925025,0.001840542,GPER1/PTH1R,2
GO:0043502,BP,GO:0043502,regulation of muscle adaptation,3月20日,95/18800,0.000133884,0.003947517,0.001851089,PPP3CA/ATP2A2/NOTCH1,3
GO:0003300,BP,GO:0003300,cardiac muscle hypertrophy,3月20日,96/18800,0.000138109,0.003947517,0.001851089,PPP3CA/ATP2A2/NOTCH1,3
GO:0003015,BP,GO:0003015,heart process,4月20日,257/18800,0.000139108,0.003947517,0.001851089,YWHAE/ATP1B1/ATP2B3/ATP2A2,4
GO:0034976,BP,GO:0034976,response to endoplasmic reticulum stress,4月20日,257/18800,0.000139108,0.003947517,0.001851089,GRINA/ITPR1/ATP2A2/ATF4,4
GO:1903522,BP,GO:1903522,regulation of blood circulation,4月20日,260/18800,0.000145459,0.004051297,0.001899754,YWHAE/ATP1B1/ATP2B3/ATP2A2,4
GO:0014897,BP,GO:0014897,striated muscle hypertrophy,3月20日,99/18800,0.000151303,0.004137457,0.001940157,PPP3CA/ATP2A2/NOTCH1,3
GO:0014896,BP,GO:0014896,muscle hypertrophy,3月20日,101/18800,0.00016054,0.004222468,0.001980021,PPP3CA/ATP2A2/NOTCH1,3
GO:0070167,BP,GO:0070167,regulation of biomineral tissue development,3月20日,101/18800,0.00016054,0.004222468,0.001980021,FZD9/NOTCH1/ATF4,3
GO:0001696,BP,GO:0001696,gastric acid secretion,2月20日,18/18800,0.000162835,0.004222468,0.001980021,SNX10/CCKBR,2
GO:0110149,BP,GO:0110149,regulation of biomineralization,3月20日,103/18800,0.000170136,0.004337021,0.002033738,FZD9/NOTCH1/ATF4,3
GO:0043270,BP,GO:0043270,positive regulation of ion transport,4月20日,273/18800,0.000175435,0.004397583,0.002062136,TSPO/ATP1B1/GPER1/ATF4,4
GO:0051900,BP,GO:0051900,regulation of mitochondrial depolarization,2月20日,19/18800,0.000181875,0.004484273,0.002102788,TSPO/FZD9,2
GO:0043266,BP,GO:0043266,regulation of potassium ion transport,3月20日,110/18800,0.000206642,0.005012726,0.002350593,YWHAE/ATP1B1/ATF4,3
GO:0051882,BP,GO:0051882,mitochondrial depolarization,2月20日,21/18800,0.000223071,0.005242167,0.002458183,TSPO/FZD9,2
GO:0070262,BP,GO:0070262,peptidyl-serine dephosphorylation,2月20日,21/18800,0.000223071,0.005242167,0.002458183,PPP3CA/YWHAE,2
GO:0019751,BP,GO:0019751,polyol metabolic process,3月20日,116/18800,0.000241695,0.005577465,0.002615413,ITPKB/GPER1/PTH1R,3
GO:0010042,BP,GO:0010042,response to manganese ion,2月20日,22/18800,0.000245222,0.005577465,0.002615413,TSPO/ATF4,2
GO:0036293,BP,GO:0036293,response to decreased oxygen levels,4月20日,299/18800,0.000248464,0.005577465,0.002615413,ATP1B1/ITPR1/NOTCH1/ATF4,4
GO:0043500,BP,GO:0043500,muscle adaptation,3月20日,118/18800,0.000254182,0.0056219,0.002636249,PPP3CA/ATP2A2/NOTCH1,3
GO:0051928,BP,GO:0051928,positive regulation of calcium ion transport,3月20日,119/18800,0.000260579,0.005679856,0.002663427,TSPO/ATP1B1/GPER1,3
GO:0014902,BP,GO:0014902,myotube differentiation,3月20日,122/18800,0.000280393,0.006024435,0.002825008,XK/PPP3CA/NOTCH1,3
GO:0036003,BP,GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress,2月20日,24/18800,0.000292618,0.006028738,0.002827026,NOTCH1/ATF4,2
GO:0043501,BP,GO:0043501,skeletal muscle adaptation,2月20日,24/18800,0.000292618,0.006028738,0.002827026,PPP3CA/ATP2A2,2
GO:1901522,BP,GO:1901522,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,2月20日,24/18800,0.000292618,0.006028738,0.002827026,NOTCH1/ATF4,2
GO:0086013,BP,GO:0086013,membrane repolarization during cardiac muscle cell action potential,2月20日,25/18800,0.00031786,0.0064603,0.003029396,YWHAE/ATP1B1,2
GO:0070482,BP,GO:0070482,response to oxygen levels,4月20日,324/18800,0.000337292,0.006763836,0.003171732,ATP1B1/ITPR1/NOTCH1/ATF4,4
GO:0010882,BP,GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,2月20日,26/18800,0.000344129,0.006810137,0.003193443,ATP1B1/ATP2A2,2
GO:0071333,BP,GO:0071333,cellular response to glucose stimulus,3月20日,132/18800,0.000353413,0.006903038,0.003237007,PPP3CB/PPP3CA/GPER1,3
GO:0071331,BP,GO:0071331,cellular response to hexose stimulus,3月20日,134/18800,0.000369348,0.007071133,0.003315831,PPP3CB/PPP3CA/GPER1,3
GO:1902932,BP,GO:1902932,positive regulation of alcohol biosynthetic process,2月20日,27/18800,0.000371423,0.007071133,0.003315831,GPER1/PTH1R,2
GO:0071326,BP,GO:0071326,cellular response to monosaccharide stimulus,3月20日,136/18800,0.000385739,0.007251898,0.003400596,PPP3CB/PPP3CA/GPER1,3
GO:1903779,BP,GO:1903779,regulation of cardiac conduction,2月20日,28/18800,0.000399738,0.007422304,0.003480504,ATP2B3/ATP2A2,2
GO:0050768,BP,GO:0050768,negative regulation of neurogenesis,3月20日,140/18800,0.000419914,0.007701833,0.003611582,PPP3CA/TSPO/NOTCH1,3
GO:0046165,BP,GO:0046165,alcohol biosynthetic process,3月20日,143/18800,0.000446784,0.007988748,0.003746123,ITPKB/GPER1/PTH1R,3
GO:0010038,BP,GO:0010038,response to metal ion,4月20日,351/18800,0.00045672,0.007988748,0.003746123,PPP3CA/TSPO/ITPKB/ATF4,4
GO:0060251,BP,GO:0060251,regulation of glial cell proliferation,2月20日,30/18800,0.00045943,0.007988748,0.003746123,TSPO/NOTCH1,2
GO:0086011,BP,GO:0086011,membrane repolarization during action potential,2月20日,30/18800,0.00045943,0.007988748,0.003746123,YWHAE/ATP1B1,2
GO:0051961,BP,GO:0051961,negative regulation of nervous system development,3月20日,145/18800,0.000465299,0.007988748,0.003746123,PPP3CA/TSPO/NOTCH1,3
GO:0050796,BP,GO:0050796,regulation of insulin secretion,3月20日,147/18800,0.0004843,0.007988748,0.003746123,PPP3CB/PPP3CA/GPER1,3
GO:0071322,BP,GO:0071322,cellular response to carbohydrate stimulus,3月20日,147/18800,0.0004843,0.007988748,0.003746123,PPP3CB/PPP3CA/GPER1,3
GO:0003299,BP,GO:0003299,muscle hypertrophy in response to stress,2月20日,31/18800,0.000490802,0.007988748,0.003746123,PPP3CA/ATP2A2,2
GO:0014887,BP,GO:0014887,cardiac muscle adaptation,2月20日,31/18800,0.000490802,0.007988748,0.003746123,PPP3CA/ATP2A2,2
GO:0014898,BP,GO:0014898,cardiac muscle hypertrophy in response to stress,2月20日,31/18800,0.000490802,0.007988748,0.003746123,PPP3CA/ATP2A2,2
GO:0010821,BP,GO:0010821,regulation of mitochondrion organization,3月20日,148/18800,0.000493985,0.007988748,0.003746123,TSPO/FZD9/GPER1,3
GO:0050767,BP,GO:0050767,regulation of neurogenesis,4月20日,361/18800,0.00050779,0.008124637,0.003809845,PPP3CA/TSPO/GPER1/NOTCH1,4
GO:0001678,BP,GO:0001678,cellular glucose homeostasis,3月20日,154/18800,0.000554716,0.008719861,0.004088961,PPP3CB/PPP3CA/GPER1,3
GO:0070050,BP,GO:0070050,neuron cellular homeostasis,2月20日,33/18800,0.000556587,0.008719861,0.004088961,ATP2B3/NELL2,2
GO:0007519,BP,GO:0007519,skeletal muscle tissue development,3月20日,155/18800,0.000565281,0.008764764,0.004110017,XK/PPP3CA/NOTCH1,3
GO:1903169,BP,GO:1903169,regulation of calcium ion transmembrane transport,3月20日,156/18800,0.000575974,0.008839436,0.004145032,YWHAE/ATP1B1/GPER1,3
GO:0048741,BP,GO:0048741,skeletal muscle fiber development,2月20日,35/18800,0.000626415,0.009516444,0.004462498,XK/PPP3CA,2
GO:0060538,BP,GO:0060538,skeletal muscle organ development,3月20日,167/18800,0.000702255,0.010561911,0.004952744,XK/PPP3CA/NOTCH1,3
GO:0035886,BP,GO:0035886,vascular associated smooth muscle cell differentiation,2月20日,38/18800,0.000738703,0.010904236,0.005113268,GPER1/NOTCH1,2
GO:0006937,BP,GO:0006937,regulation of muscle contraction,3月20日,170/18800,0.000739516,0.010904236,0.005113268,ATP1B1/GPER1/ATP2A2,3
GO:0014904,BP,GO:0014904,myotube cell development,2月20日,39/18800,0.000778136,0.011362297,0.005328065,XK/PPP3CA,2
GO:0048771,BP,GO:0048771,tissue remodeling,3月20日,174/18800,0.000791131,0.011440974,0.005364958,PPP3CA/SNX10/PTH1R,3
GO:0017158,BP,GO:0017158,regulation of calcium ion-dependent exocytosis,2月20日,40/18800,0.000818568,0.011614405,0.005446285,ATP2A2/NOTCH1,2
GO:0099622,BP,GO:0099622,cardiac muscle cell membrane repolarization,2月20日,40/18800,0.000818568,0.011614405,0.005446285,YWHAE/ATP1B1,2
GO:0090276,BP,GO:0090276,regulation of peptide hormone secretion,3月20日,177/18800,0.000831314,0.011685015,0.005479395,PPP3CB/PPP3CA/GPER1,3
GO:0030073,BP,GO:0030073,insulin secretion,3月20日,179/18800,0.000858813,0.011866392,0.005564448,PPP3CB/PPP3CA/GPER1,3
GO:0014014,BP,GO:0014014,negative regulation of gliogenesis,2月20日,41/18800,0.000859998,0.011866392,0.005564448,TSPO/NOTCH1,2
GO:0002791,BP,GO:0002791,regulation of peptide secretion,3月20日,180/18800,0.000872777,0.011933242,0.005595795,PPP3CB/PPP3CA/GPER1,3
GO:0010721,BP,GO:0010721,negative regulation of cell development,3月20日,181/18800,0.000886885,0.012016895,0.005635022,PPP3CA/TSPO/NOTCH1,3
GO:0090087,BP,GO:0090087,regulation of peptide transport,3月20日,183/18800,0.000915536,0.012294339,0.005765123,PPP3CB/PPP3CA/GPER1,3
GO:0014009,BP,GO:0014009,glial cell proliferation,2月20日,44/18800,0.000990248,0.012447429,0.00583691,TSPO/NOTCH1,2
GO:0033173,BP,GO:0033173,calcineurin-NFAT signaling cascade,2月20日,44/18800,0.000990248,0.012447429,0.00583691,PPP3CB/PPP3CA,2
GO:0009749,BP,GO:0009749,response to glucose,3月20日,189/18800,0.001005006,0.012447429,0.00583691,PPP3CB/PPP3CA/GPER1,3
GO:0006984,BP,GO:0006984,ER-nucleus signaling pathway,2月20日,45/18800,0.001035646,0.012447429,0.00583691,ATP2A2/ATF4,2
GO:0071248,BP,GO:0071248,cellular response to metal ion,3月20日,191/18800,0.001036018,0.012447429,0.00583691,TSPO/ITPKB/ATF4,3
GO:0003178,BP,GO:0003178,coronary sinus valve development,1月20日,1/18800,0.00106383,0.012447429,0.00583691,NOTCH1,1
GO:0003182,BP,GO:0003182,coronary sinus valve morphogenesis,1月20日,1/18800,0.00106383,0.012447429,0.00583691,NOTCH1,1
GO:0003270,BP,GO:0003270,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,1月20日,1/18800,0.00106383,0.012447429,0.00583691,NOTCH1,1
GO:0030264,BP,GO:0030264,nuclear fragmentation involved in apoptotic nuclear change,1月20日,1/18800,0.00106383,0.012447429,0.00583691,GPER1,1
GO:0033030,BP,GO:0033030,negative regulation of neutrophil apoptotic process,1月20日,1/18800,0.00106383,0.012447429,0.00583691,ITPKB,1
GO:0044861,BP,GO:0044861,protein transport into plasma membrane raft,1月20日,1/18800,0.00106383,0.012447429,0.00583691,ATP1B1,1
GO:0060843,BP,GO:0060843,venous endothelial cell differentiation,1月20日,1/18800,0.00106383,0.012447429,0.00583691,NOTCH1,1
GO:0061395,BP,GO:0061395,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,1月20日,1/18800,0.00106383,0.012447429,0.00583691,ATF4,1
GO:1903910,BP,GO:1903910,negative regulation of receptor clustering,1月20日,1/18800,0.00106383,0.012447429,0.00583691,FZD9,1
GO:1904394,BP,GO:1904394,negative regulation of skeletal muscle acetylcholine-gated channel clustering,1月20日,1/18800,0.00106383,0.012447429,0.00583691,FZD9,1
GO:0051960,BP,GO:0051960,regulation of nervous system development,4月20日,440/18800,0.001064786,0.012447429,0.00583691,PPP3CA/TSPO/GPER1/NOTCH1,4
GO:0009746,BP,GO:0009746,response to hexose,3月20日,193/18800,0.001067632,0.012447429,0.00583691,PPP3CB/PPP3CA/GPER1,3
GO:0010939,BP,GO:0010939,regulation of necrotic cell death,2月20日,46/18800,0.001082031,0.012518261,0.005870125,TSPO/FZD9,2
GO:0003254,BP,GO:0003254,regulation of membrane depolarization,2月20日,47/18800,0.001129401,0.012676258,0.005944214,TSPO/FZD9,2
GO:0043618,BP,GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,2月20日,47/18800,0.001129401,0.012676258,0.005944214,NOTCH1/ATF4,2
GO:0046717,BP,GO:0046717,acid secretion,2月20日,47/18800,0.001129401,0.012676258,0.005944214,SNX10/CCKBR,2
GO:0120163,BP,GO:0120163,negative regulation of cold-induced thermogenesis,2月20日,47/18800,0.001129401,0.012676258,0.005944214,NOTCH1/ATF4,2
GO:0023061,BP,GO:0023061,signal release,4月20日,451/18800,0.001166885,0.012893934,0.006046287,PPP3CB/PPP3CA/GPER1/ATP2A2,4
GO:0060976,BP,GO:0060976,coronary vasculature development,2月20日,48/18800,0.001177754,0.012893934,0.006046287,GPER1/NOTCH1,2
GO:0097720,BP,GO:0097720,calcineurin-mediated signaling,2月20日,48/18800,0.001177754,0.012893934,0.006046287,PPP3CB/PPP3CA,2
GO:0034284,BP,GO:0034284,response to monosaccharide,3月20日,200/18800,0.001183087,0.012893934,0.006046287,PPP3CB/PPP3CA/GPER1,3
GO:0051051,BP,GO:0051051,negative regulation of transport,4月20日,464/18800,0.00129624,0.014025501,0.006576908,PPP3CA/YWHAE/NOTCH1/ATF4,4
GO:0010823,BP,GO:0010823,negative regulation of mitochondrion organization,2月20日,51/18800,0.001328695,0.014172747,0.006645955,TSPO/FZD9,2
GO:2000179,BP,GO:2000179,positive regulation of neural precursor cell proliferation,2月20日,51/18800,0.001328695,0.014172747,0.006645955,FZD9/NOTCH1,2
GO:0016051,BP,GO:0016051,carbohydrate biosynthetic process,3月20日,209/18800,0.00134276,0.014221908,0.006669008,GPER1/PTH1R/ATF4,3
GO:0070169,BP,GO:0070169,positive regulation of biomineral tissue development,2月20日,52/18800,0.001380962,0.014323914,0.006716841,FZD9/ATF4,2
GO:0086009,BP,GO:0086009,membrane repolarization,2月20日,52/18800,0.001380962,0.014323914,0.006716841,YWHAE/ATP1B1,2
GO:1902930,BP,GO:1902930,regulation of alcohol biosynthetic process,2月20日,52/18800,0.001380962,0.014323914,0.006716841,GPER1/PTH1R,2
GO:0043620,BP,GO:0043620,regulation of DNA-templated transcription in response to stress,2月20日,53/18800,0.001434204,0.014673756,0.006880891,NOTCH1/ATF4,2
GO:0110151,BP,GO:0110151,positive regulation of biomineralization,2月20日,53/18800,0.001434204,0.014673756,0.006880891,FZD9/ATF4,2
GO:0061564,BP,GO:0061564,axon development,4月20日,479/18800,0.001457689,0.014813269,0.006946312,XK/PPP3CB/TSPO/NOTCH1,4
GO:0014888,BP,GO:0014888,striated muscle adaptation,2月20日,54/18800,0.001488416,0.015024015,0.007045136,PPP3CA/ATP2A2,2
GO:0051651,BP,GO:0051651,maintenance of location in cell,3月20日,219/18800,0.001535446,0.015395402,0.007219288,TSPO/GPER1/ITPR1,3
GO:0030072,BP,GO:0030072,peptide hormone secretion,3月20日,220/18800,0.001555618,0.015494368,0.007265696,PPP3CB/PPP3CA/GPER1,3
GO:0071241,BP,GO:0071241,cellular response to inorganic substance,3月20日,221/18800,0.001575957,0.015522734,0.007278997,TSPO/ITPKB/ATF4,3
GO:0050769,BP,GO:0050769,positive regulation of neurogenesis,3月20日,222/18800,0.001596463,0.015522734,0.007278997,TSPO/GPER1/NOTCH1,3
GO:0001836,BP,GO:0001836,release of cytochrome c from mitochondria,2月20日,56/18800,0.00159975,0.015522734,0.007278997,FZD9/GPER1,2
GO:0010676,BP,GO:0010676,positive regulation of cellular carbohydrate metabolic process,2月20日,56/18800,0.00159975,0.015522734,0.007278997,GPER1/PTH1R,2
GO:0051223,BP,GO:0051223,regulation of protein transport,4月20日,495/18800,0.001644955,0.015791877,0.007405206,PPP3CB/PPP3CA/YWHAE/GPER1,4
GO:0010817,BP,GO:0010817,regulation of hormone levels,4月20日,496/18800,0.001657191,0.015791877,0.007405206,PPP3CB/PPP3CA/TSPO/GPER1,4
GO:0002790,BP,GO:0002790,peptide secretion,3月20日,225/18800,0.001658987,0.015791877,0.007405206,PPP3CB/PPP3CA/GPER1,3
GO:0009743,BP,GO:0009743,response to carbohydrate,3月20日,226/18800,0.001680166,0.01589289,0.007452573,PPP3CB/PPP3CA/GPER1,3
GO:0060284,BP,GO:0060284,regulation of cell development,4月20日,500/18800,0.001706776,0.016043694,0.007523289,PPP3CA/TSPO/GPER1/NOTCH1,4
GO:0046883,BP,GO:0046883,regulation of hormone secretion,3月20日,231/18800,0.001788613,0.016708537,0.00783505,PPP3CB/PPP3CA/GPER1,3
GO:0045055,BP,GO:0045055,regulated exocytosis,3月20日,234/18800,0.001855743,0.017228622,0.008078931,PPP3CB/ATP2A2/NOTCH1,3
GO:0007405,BP,GO:0007405,neuroblast proliferation,2月20日,61/18800,0.001894955,0.01748474,0.008199031,FZD9/NOTCH1,2
GO:0046579,BP,GO:0046579,positive regulation of Ras protein signal transduction,2月20日,62/18800,0.001956873,0.017573532,0.008240668,ITPKB/NOTCH1,2
GO:0001649,BP,GO:0001649,osteoblast differentiation,3月20日,241/18800,0.002018475,0.017573532,0.008240668,PTH1R/NOTCH1/ATF4,3
GO:0045453,BP,GO:0045453,bone resorption,2月20日,63/18800,0.002019746,0.017573532,0.008240668,SNX10/PTH1R,2
GO:0006813,BP,GO:0006813,potassium ion transport,3月20日,243/18800,0.002066556,0.017573532,0.008240668,YWHAE/ATP1B1/ATF4,3
GO:1901617,BP,GO:1901617,organic hydroxy compound biosynthetic process,3月20日,243/18800,0.002066556,0.017573532,0.008240668,ITPKB/GPER1/PTH1R,3
GO:0014015,BP,GO:0014015,positive regulation of gliogenesis,2月20日,64/18800,0.002083572,0.017573532,0.008240668,TSPO/NOTCH1,2
GO:0042593,BP,GO:0042593,glucose homeostasis,3月20日,244/18800,0.002090863,0.017573532,0.008240668,PPP3CB/PPP3CA/GPER1,3
GO:0033500,BP,GO:0033500,carbohydrate homeostasis,3月20日,245/18800,0.002115348,0.017573532,0.008240668,PPP3CB/PPP3CA/GPER1,3
GO:0003064,BP,GO:0003064,regulation of heart rate by hormone,1月20日,2/18800,0.002126584,0.017573532,0.008240668,YWHAE,1
GO:0003169,BP,GO:0003169,coronary vein morphogenesis,1月20日,2/18800,0.002126584,0.017573532,0.008240668,NOTCH1,1
GO:0003252,BP,GO:0003252,negative regulation of cell proliferation involved in heart valve morphogenesis,1月20日,2/18800,0.002126584,0.017573532,0.008240668,NOTCH1,1
GO:0010266,BP,GO:0010266,response to vitamin B1,1月20日,2/18800,0.002126584,0.017573532,0.008240668,TSPO,1
GO:0038188,BP,GO:0038188,cholecystokinin signaling pathway,1月20日,2/18800,0.002126584,0.017573532,0.008240668,CCKBR,1
GO:0060528,BP,GO:0060528,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,1月20日,2/18800,0.002126584,0.017573532,0.008240668,NOTCH1,1
GO:0061394,BP,GO:0061394,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,1月20日,2/18800,0.002126584,0.017573532,0.008240668,ATF4,1
GO:0070982,BP,GO:0070982,L-asparagine metabolic process,1月20日,2/18800,0.002126584,0.017573532,0.008240668,ATF4,1
GO:1903281,BP,GO:1903281,positive regulation of calcium:sodium antiporter activity,1月20日,2/18800,0.002126584,0.017573532,0.008240668,ATP1B1,1
GO:1903515,BP,GO:1903515,calcium ion transport from cytosol to endoplasmic reticulum,1月20日,2/18800,0.002126584,0.017573532,0.008240668,ATP2A2,1
GO:1903849,BP,GO:1903849,positive regulation of aorta morphogenesis,1月20日,2/18800,0.002126584,0.017573532,0.008240668,NOTCH1,1
GO:0070265,BP,GO:0070265,necrotic cell death,2月20日,66/18800,0.002214073,0.018105903,0.00849031,TSPO/FZD9,2
GO:0015833,BP,GO:0015833,peptide transport,3月20日,249/18800,0.002215084,0.018105903,0.00849031,PPP3CB/PPP3CA/GPER1,3
GO:0032024,BP,GO:0032024,positive regulation of insulin secretion,2月20日,67/18800,0.002280745,0.018432303,0.008643367,PPP3CB/GPER1,2
GO:1901016,BP,GO:1901016,regulation of potassium ion transmembrane transporter activity,2月20日,67/18800,0.002280745,0.018432303,0.008643367,YWHAE/ATP1B1,2
GO:0050708,BP,GO:0050708,regulation of protein secretion,3月20日,252/18800,0.002291782,0.018432303,0.008643367,PPP3CB/PPP3CA/GPER1,3
GO:0010611,BP,GO:0010611,regulation of cardiac muscle hypertrophy,2月20日,68/18800,0.002348363,0.018786902,0.008809647,PPP3CA/NOTCH1,2
GO:0051057,BP,GO:0051057,positive regulation of small GTPase mediated signal transduction,2月20日,70/18800,0.002486425,0.019786158,0.009278224,ITPKB/NOTCH1,2
GO:0014743,BP,GO:0014743,regulation of muscle hypertrophy,2月20日,71/18800,0.002556867,0.020028792,0.009392001,PPP3CA/NOTCH1,2
GO:0051881,BP,GO:0051881,regulation of mitochondrial membrane potential,2月20日,71/18800,0.002556867,0.020028792,0.009392001,TSPO/FZD9,2
GO:1904427,BP,GO:1904427,positive regulation of calcium ion transmembrane transport,2月20日,71/18800,0.002556867,0.020028792,0.009392001,ATP1B1/GPER1,2
GO:0033555,BP,GO:0033555,multicellular organismal response to stress,2月20日,73/18800,0.002700561,0.020936309,0.009817558,PPP3CA/TSPO,2
GO:0051145,BP,GO:0051145,smooth muscle cell differentiation,2月20日,73/18800,0.002700561,0.020936309,0.009817558,GPER1/NOTCH1,2
GO:0051962,BP,GO:0051962,positive regulation of nervous system development,3月20日,270/18800,0.002786837,0.021494377,0.01007925,TSPO/GPER1/NOTCH1,3
GO:0001894,BP,GO:0001894,tissue homeostasis,3月20日,272/18800,0.002845602,0.021796137,0.010220753,SNX10/PTH1R/NOTCH1,3
GO:0045913,BP,GO:0045913,positive regulation of carbohydrate metabolic process,2月20日,77/18800,0.002999141,0.021796137,0.010220753,GPER1/PTH1R,2
GO:0055117,BP,GO:0055117,regulation of cardiac muscle contraction,2月20日,77/18800,0.002999141,0.021796137,0.010220753,ATP1B1/ATP2A2,2
GO:0046879,BP,GO:0046879,hormone secretion,3月20日,281/18800,0.003119549,0.021796137,0.010220753,PPP3CB/PPP3CA/GPER1,3
GO:0051146,BP,GO:0051146,striated muscle cell differentiation,3月20日,281/18800,0.003119549,0.021796137,0.010220753,XK/PPP3CA/NOTCH1,3
GO:0048872,BP,GO:0048872,homeostasis of number of cells,3月20日,282/18800,0.003150956,0.021796137,0.010220753,PPP3CB/ITPKB/NOTCH1,3
GO:0003192,BP,GO:0003192,mitral valve formation,1月20日,3/18800,0.003188265,0.021796137,0.010220753,NOTCH1,1
GO:0003213,BP,GO:0003213,cardiac right atrium morphogenesis,1月20日,3/18800,0.003188265,0.021796137,0.010220753,NOTCH1,1
GO:0003249,BP,GO:0003249,cell proliferation involved in heart valve morphogenesis,1月20日,3/18800,0.003188265,0.021796137,0.010220753,NOTCH1,1
GO:0003250,BP,GO:0003250,regulation of cell proliferation involved in heart valve morphogenesis,1月20日,3/18800,0.003188265,0.021796137,0.010220753,NOTCH1,1
GO:0032470,BP,GO:0032470,positive regulation of endoplasmic reticulum calcium ion concentration,1月20日,3/18800,0.003188265,0.021796137,0.010220753,ATP2A2,1
GO:0044860,BP,GO:0044860,protein localization to plasma membrane raft,1月20日,3/18800,0.003188265,0.021796137,0.010220753,ATP1B1,1
GO:0045851,BP,GO:0045851,pH reduction,1月20日,3/18800,0.003188265,0.021796137,0.010220753,CCKBR,1
GO:0060948,BP,GO:0060948,cardiac vascular smooth muscle cell development,1月20日,3/18800,0.003188265,0.021796137,0.010220753,NOTCH1,1
GO:0140468,BP,GO:0140468,HRI-mediated signaling,1月20日,3/18800,0.003188265,0.021796137,0.010220753,ATF4,1
GO:1902263,BP,GO:1902263,apoptotic process involved in embryonic digit morphogenesis,1月20日,3/18800,0.003188265,0.021796137,0.010220753,NOTCH1,1
GO:1902309,BP,GO:1902309,negative regulation of peptidyl-serine dephosphorylation,1月20日,3/18800,0.003188265,0.021796137,0.010220753,YWHAE,1
GO:1903279,BP,GO:1903279,regulation of calcium:sodium antiporter activity,1月20日,3/18800,0.003188265,0.021796137,0.010220753,ATP1B1,1
GO:1903406,BP,GO:1903406,regulation of P-type sodium:potassium-exchanging transporter activity,1月20日,3/18800,0.003188265,0.021796137,0.010220753,ATP1B1,1
GO:1903408,BP,GO:1903408,positive regulation of P-type sodium:potassium-exchanging transporter activity,1月20日,3/18800,0.003188265,0.021796137,0.010220753,ATP1B1,1
GO:1905457,BP,GO:1905457,negative regulation of lymphoid progenitor cell differentiation,1月20日,3/18800,0.003188265,0.021796137,0.010220753,NOTCH1,1
GO:1990523,BP,GO:1990523,bone regeneration,1月20日,3/18800,0.003188265,0.021796137,0.010220753,FZD9,1
GO:1990737,BP,GO:1990737,response to manganese-induced endoplasmic reticulum stress,1月20日,3/18800,0.003188265,0.021796137,0.010220753,ATF4,1
GO:2000120,BP,GO:2000120,positive regulation of sodium-dependent phosphate transport,1月20日,3/18800,0.003188265,0.021796137,0.010220753,ATF4,1
GO:2000974,BP,GO:2000974,negative regulation of pro-B cell differentiation,1月20日,3/18800,0.003188265,0.021796137,0.010220753,NOTCH1,1
GO:0001666,BP,GO:0001666,response to hypoxia,3月20日,286/18800,0.003278543,0.022311896,0.010462605,ATP1B1/ITPR1/NOTCH1,3
GO:0042886,BP,GO:0042886,amide transport,3月20日,287/18800,0.003310931,0.022430814,0.010518369,PPP3CB/PPP3CA/GPER1,3
GO:0009914,BP,GO:0009914,hormone transport,3月20日,290/18800,0.003409281,0.022993537,0.010782244,PPP3CB/PPP3CA/GPER1,3
GO:0006470,BP,GO:0006470,protein dephosphorylation,3月20日,291/18800,0.003442461,0.023113666,0.010838575,PPP3CB/PPP3CA/YWHAE,3
GO:0051222,BP,GO:0051222,positive regulation of protein transport,3月20日,293/18800,0.003509418,0.023458508,0.01100028,PPP3CB/YWHAE/GPER1,3
GO:0034504,BP,GO:0034504,protein localization to nucleus,3月20日,294/18800,0.003543196,0.023568768,0.011051984,PPP3CA/YWHAE/NOTCH1,3
GO:0051899,BP,GO:0051899,membrane depolarization,2月20日,84/18800,0.003557254,0.023568768,0.011051984,TSPO/FZD9,2
GO:0097193,BP,GO:0097193,intrinsic apoptotic signaling pathway,3月20日,295/18800,0.003577173,0.023596793,0.011065126,GRINA/ITPR1/ATF4,3
GO:2000177,BP,GO:2000177,regulation of neural precursor cell proliferation,2月20日,85/18800,0.003640653,0.023839911,0.01117913,FZD9/NOTCH1,2
GO:0010720,BP,GO:0010720,positive regulation of cell development,3月20日,297/18800,0.003645731,0.023839911,0.01117913,TSPO/GPER1/NOTCH1,3
GO:0046928,BP,GO:0046928,regulation of neurotransmitter secretion,2月20日,86/18800,0.003724964,0.024252582,0.011372641,GPER1/ATP2A2,2
GO:0046849,BP,GO:0046849,bone remodeling,2月20日,88/18800,0.003896314,0.024768618,0.011614624,SNX10/PTH1R,2
GO:0001776,BP,GO:0001776,leukocyte homeostasis,2月20日,89/18800,0.003983349,0.024768618,0.011614624,PPP3CB/ITPKB,2
GO:0006913,BP,GO:0006913,nucleocytoplasmic transport,3月20日,308/18800,0.004037272,0.024768618,0.011614624,PPP3CA/YWHAE/NOTCH1,3
GO:0051169,BP,GO:0051169,nuclear transport,3月20日,308/18800,0.004037272,0.024768618,0.011614624,PPP3CA/YWHAE/NOTCH1,3
GO:1904951,BP,GO:1904951,positive regulation of establishment of protein localization,3月20日,309/18800,0.004074091,0.024768618,0.011614624,PPP3CB/YWHAE/GPER1,3
GO:0045638,BP,GO:0045638,negative regulation of myeloid cell differentiation,2月20日,91/18800,0.00416013,0.024768618,0.011614624,ITPKB/TMEM178A,2
GO:0090277,BP,GO:0090277,positive regulation of peptide hormone secretion,2月20日,91/18800,0.00416013,0.024768618,0.011614624,PPP3CB/GPER1,2
GO:1901019,BP,GO:1901019,regulation of calcium ion transmembrane transporter activity,2月20日,91/18800,0.00416013,0.024768618,0.011614624,YWHAE/ATP1B1,2
GO:0003219,BP,GO:0003219,cardiac right ventricle formation,1月20日,4/18800,0.004248872,0.024768618,0.011614624,NOTCH1,1
GO:0003273,BP,GO:0003273,cell migration involved in endocardial cushion formation,1月20日,4/18800,0.004248872,0.024768618,0.011614624,NOTCH1,1
GO:0003332,BP,GO:0003332,negative regulation of extracellular matrix constituent secretion,1月20日,4/18800,0.004248872,0.024768618,0.011614624,NOTCH1,1
GO:0032057,BP,GO:0032057,negative regulation of translational initiation in response to stress,1月20日,4/18800,0.004248872,0.024768618,0.011614624,ATF4,1
GO:0032596,BP,GO:0032596,protein transport into membrane raft,1月20日,4/18800,0.004248872,0.024768618,0.011614624,ATP1B1,1
GO:0045608,BP,GO:0045608,negative regulation of inner ear auditory receptor cell differentiation,1月20日,4/18800,0.004248872,0.024768618,0.011614624,NOTCH1,1
GO:0045632,BP,GO:0045632,negative regulation of mechanoreceptor differentiation,1月20日,4/18800,0.004248872,0.024768618,0.011614624,NOTCH1,1
GO:0046967,BP,GO:0046967,cytosol to endoplasmic reticulum transport,1月20日,4/18800,0.004248872,0.024768618,0.011614624,ATP2A2,1
GO:0071228,BP,GO:0071228,cellular response to tumor cell,1月20日,4/18800,0.004248872,0.024768618,0.011614624,NOTCH1,1
GO:1902308,BP,GO:1902308,regulation of peptidyl-serine dephosphorylation,1月20日,4/18800,0.004248872,0.024768618,0.011614624,YWHAE,1
GO:1903233,BP,GO:1903233,regulation of calcium ion-dependent exocytosis of neurotransmitter,1月20日,4/18800,0.004248872,0.024768618,0.011614624,ATP2A2,1
GO:1903276,BP,GO:1903276,regulation of sodium ion export across plasma membrane,1月20日,4/18800,0.004248872,0.024768618,0.011614624,ATP1B1,1
GO:1903278,BP,GO:1903278,positive regulation of sodium ion export across plasma membrane,1月20日,4/18800,0.004248872,0.024768618,0.011614624,ATP1B1,1
GO:1903847,BP,GO:1903847,regulation of aorta morphogenesis,1月20日,4/18800,0.004248872,0.024768618,0.011614624,NOTCH1,1
GO:1904393,BP,GO:1904393,regulation of skeletal muscle acetylcholine-gated channel clustering,1月20日,4/18800,0.004248872,0.024768618,0.011614624,FZD9,1
GO:1905653,BP,GO:1905653,positive regulation of artery morphogenesis,1月20日,4/18800,0.004248872,0.024768618,0.011614624,NOTCH1,1
GO:2000724,BP,GO:2000724,positive regulation of cardiac vascular smooth muscle cell differentiation,1月20日,4/18800,0.004248872,0.024768618,0.011614624,GPER1,1
GO:2000793,BP,GO:2000793,cell proliferation involved in heart valve development,1月20日,4/18800,0.004248872,0.024768618,0.011614624,NOTCH1,1
GO:2000981,BP,GO:2000981,negative regulation of inner ear receptor cell differentiation,1月20日,4/18800,0.004248872,0.024768618,0.011614624,NOTCH1,1
GO:0002793,BP,GO:0002793,positive regulation of peptide secretion,2月20日,93/18800,0.004340514,0.025205146,0.011819322,PPP3CB/GPER1,2
GO:1901379,BP,GO:1901379,regulation of potassium ion transmembrane transport,2月20日,95/18800,0.004524486,0.026172411,0.012272897,YWHAE/ATP1B1,2
GO:0006942,BP,GO:0006942,regulation of striated muscle contraction,2月20日,96/18800,0.004617813,0.026508363,0.012430433,ATP1B1/ATP2A2,2
GO:0030316,BP,GO:0030316,osteoclast differentiation,2月20日,96/18800,0.004617813,0.026508363,0.012430433,SNX10/TMEM178A,2
GO:0007204,BP,GO:0007204,positive regulation of cytosolic calcium ion concentration,3月20日,325/18800,0.00469144,0.026828618,0.012580609,GPER1/ITPR1/CCKBR,3
GO:0048545,BP,GO:0048545,response to steroid hormone,3月20日,330/18800,0.004895397,0.027530498,0.012909738,TSPO/GPER1/NOTCH1,3
GO:0051588,BP,GO:0051588,regulation of neurotransmitter transport,2月20日,99/18800,0.004903137,0.027530498,0.012909738,GPER1/ATP2A2,2
GO:0051235,BP,GO:0051235,maintenance of location,3月20日,331/18800,0.004936826,0.027530498,0.012909738,TSPO/GPER1/ITPR1,3
GO:0062197,BP,GO:0062197,cellular response to chemical stress,3月20日,332/18800,0.004978469,0.027530498,0.012909738,TSPO/ATP2A2/ATF4,3
GO:0014013,BP,GO:0014013,regulation of gliogenesis,2月20日,100/18800,0.00500002,0.027530498,0.012909738,TSPO/NOTCH1,2
GO:0007517,BP,GO:0007517,muscle organ development,3月20日,334/18800,0.005062396,0.027530498,0.012909738,XK/PPP3CA/NOTCH1,3
GO:0043255,BP,GO:0043255,regulation of carbohydrate biosynthetic process,2月20日,102/18800,0.005196437,0.027530498,0.012909738,GPER1/PTH1R,2
GO:0003241,BP,GO:0003241,growth involved in heart morphogenesis,1月20日,5/18800,0.005308407,0.027530498,0.012909738,NOTCH1,1
GO:0006528,BP,GO:0006528,asparagine metabolic process,1月20日,5/18800,0.005308407,0.027530498,0.012909738,ATF4,1
GO:0007386,BP,GO:0007386,compartment pattern specification,1月20日,5/18800,0.005308407,0.027530498,0.012909738,NOTCH1,1
GO:0009912,BP,GO:0009912,auditory receptor cell fate commitment,1月20日,5/18800,0.005308407,0.027530498,0.012909738,NOTCH1,1
GO:0010961,BP,GO:0010961,cellular magnesium ion homeostasis,1月20日,5/18800,0.005308407,0.027530498,0.012909738,XK,1
GO:0030263,BP,GO:0030263,apoptotic chromosome condensation,1月20日,5/18800,0.005308407,0.027530498,0.012909738,GPER1,1
GO:0031133,BP,GO:0031133,regulation of axon diameter,1月20日,5/18800,0.005308407,0.027530498,0.012909738,XK,1
GO:0032962,BP,GO:0032962,positive regulation of inositol trisphosphate biosynthetic process,1月20日,5/18800,0.005308407,0.027530498,0.012909738,GPER1,1
GO:0036091,BP,GO:0036091,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,1月20日,5/18800,0.005308407,0.027530498,0.012909738,ATF4,1
GO:0060120,BP,GO:0060120,inner ear receptor cell fate commitment,1月20日,5/18800,0.005308407,0.027530498,0.012909738,NOTCH1,1
GO:0060979,BP,GO:0060979,vasculogenesis involved in coronary vascular morphogenesis,1月20日,5/18800,0.005308407,0.027530498,0.012909738,NOTCH1,1
GO:0072144,BP,GO:0072144,glomerular mesangial cell development,1月20日,5/18800,0.005308407,0.027530498,0.012909738,NOTCH1,1
GO:0072656,BP,GO:0072656,maintenance of protein location in mitochondrion,1月20日,5/18800,0.005308407,0.027530498,0.012909738,TSPO,1
GO:0090650,BP,GO:0090650,cellular response to oxygen-glucose deprivation,1月20日,5/18800,0.005308407,0.027530498,0.012909738,ATF4,1
GO:1902339,BP,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,1月20日,5/18800,0.005308407,0.027530498,0.012909738,NOTCH1,1
GO:1905912,BP,GO:1905912,regulation of calcium ion export across plasma membrane,1月20日,5/18800,0.005308407,0.027530498,0.012909738,YWHAE,1
GO:1905913,BP,GO:1905913,negative regulation of calcium ion export across plasma membrane,1月20日,5/18800,0.005308407,0.027530498,0.012909738,YWHAE,1
GO:2000118,BP,GO:2000118,regulation of sodium-dependent phosphate transport,1月20日,5/18800,0.005308407,0.027530498,0.012909738,ATF4,1
GO:2000137,BP,GO:2000137,negative regulation of cell proliferation involved in heart morphogenesis,1月20日,5/18800,0.005308407,0.027530498,0.012909738,NOTCH1,1
GO:2000722,BP,GO:2000722,regulation of cardiac vascular smooth muscle cell differentiation,1月20日,5/18800,0.005308407,0.027530498,0.012909738,GPER1,1
GO:0007200,BP,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,2月20日,104/18800,0.005396378,0.027795042,0.013033789,CCKBR/PTH1R,2
GO:0022600,BP,GO:0022600,digestive system process,2月20日,104/18800,0.005396378,0.027795042,0.013033789,SNX10/CCKBR,2
GO:0002027,BP,GO:0002027,regulation of heart rate,2月20日,105/18800,0.005497665,0.028220095,0.013233107,YWHAE/ATP2A2,2
GO:0008637,BP,GO:0008637,apoptotic mitochondrial changes,2月20日,107/18800,0.005702863,0.029159121,0.01367344,FZD9/GPER1,2
GO:0006936,BP,GO:0006936,muscle contraction,3月20日,349/18800,0.005719376,0.029159121,0.01367344,ATP1B1/GPER1/ATP2A2,3
GO:0009306,BP,GO:0009306,protein secretion,3月20日,350/18800,0.005764916,0.029292007,0.013735754,PPP3CB/PPP3CA/GPER1,3
GO:0035592,BP,GO:0035592,establishment of protein localization to extracellular region,3月20日,351/18800,0.005810677,0.02942511,0.013798169,PPP3CB/PPP3CA/GPER1,3
GO:1904062,BP,GO:1904062,regulation of cation transmembrane transport,3月20日,352/18800,0.005856657,0.029558429,0.013860685,YWHAE/ATP1B1/GPER1,3
GO:0006887,BP,GO:0006887,exocytosis,3月20日,357/18800,0.006089865,0.030112498,0.014120502,PPP3CB/ATP2A2/NOTCH1,3
GO:0071692,BP,GO:0071692,protein localization to extracellular region,3月20日,359/18800,0.006184698,0.030112498,0.014120502,PPP3CB/PPP3CA/GPER1,3
GO:0006066,BP,GO:0006066,alcohol metabolic process,3月20日,361/18800,0.00628042,0.030112498,0.014120502,ITPKB/GPER1/PTH1R,3
GO:0003160,BP,GO:0003160,endocardium morphogenesis,1月20日,6/18800,0.006366871,0.030112498,0.014120502,NOTCH1,1
GO:0003348,BP,GO:0003348,cardiac endothelial cell differentiation,1月20日,6/18800,0.006366871,0.030112498,0.014120502,NOTCH1,1
GO:0010966,BP,GO:0010966,regulation of phosphate transport,1月20日,6/18800,0.006366871,0.030112498,0.014120502,ATF4,1
GO:0014807,BP,GO:0014807,regulation of somitogenesis,1月20日,6/18800,0.006366871,0.030112498,0.014120502,NOTCH1,1
GO:0032594,BP,GO:0032594,protein transport within lipid bilayer,1月20日,6/18800,0.006366871,0.030112498,0.014120502,ATP1B1,1
GO:0032960,BP,GO:0032960,regulation of inositol trisphosphate biosynthetic process,1月20日,6/18800,0.006366871,0.030112498,0.014120502,GPER1,1
GO:0033029,BP,GO:0033029,regulation of neutrophil apoptotic process,1月20日,6/18800,0.006366871,0.030112498,0.014120502,ITPKB,1
GO:0046533,BP,GO:0046533,negative regulation of photoreceptor cell differentiation,1月20日,6/18800,0.006366871,0.030112498,0.014120502,NOTCH1,1
GO:0051902,BP,GO:0051902,negative regulation of mitochondrial depolarization,1月20日,6/18800,0.006366871,0.030112498,0.014120502,FZD9,1
GO:0060842,BP,GO:0060842,arterial endothelial cell differentiation,1月20日,6/18800,0.006366871,0.030112498,0.014120502,NOTCH1,1
GO:0060956,BP,GO:0060956,endocardial cell differentiation,1月20日,6/18800,0.006366871,0.030112498,0.014120502,NOTCH1,1
GO:0061419,BP,GO:0061419,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,1月20日,6/18800,0.006366871,0.030112498,0.014120502,NOTCH1,1
GO:0070309,BP,GO:0070309,lens fiber cell morphogenesis,1月20日,6/18800,0.006366871,0.030112498,0.014120502,ATF4,1
GO:0072008,BP,GO:0072008,glomerular mesangial cell differentiation,1月20日,6/18800,0.006366871,0.030112498,0.014120502,NOTCH1,1
GO:0072143,BP,GO:0072143,mesangial cell development,1月20日,6/18800,0.006366871,0.030112498,0.014120502,NOTCH1,1
GO:1904747,BP,GO:1904747,positive regulation of apoptotic process involved in development,1月20日,6/18800,0.006366871,0.030112498,0.014120502,NOTCH1,1
GO:1990036,BP,GO:1990036,calcium ion import into sarcoplasmic reticulum,1月20日,6/18800,0.006366871,0.030112498,0.014120502,ATP2A2,1
GO:2001233,BP,GO:2001233,regulation of apoptotic signaling pathway,3月20日,370/18800,0.006722227,0.031693508,0.014861877,FZD9/GPER1/GRINA,3
GO:0030278,BP,GO:0030278,regulation of ossification,2月20日,118/18800,0.006893415,0.032399049,0.015192723,FZD9/NOTCH1,2
GO:0051209,BP,GO:0051209,release of sequestered calcium ion into cytosol,2月20日,121/18800,0.007236111,0.032745146,0.015355017,GPER1/ITPR1,2
GO:0030098,BP,GO:0030098,lymphocyte differentiation,3月20日,382/18800,0.007339725,0.032745146,0.015355017,PPP3CB/FZD9/ITPKB,3
GO:0046887,BP,GO:0046887,positive regulation of hormone secretion,2月20日,122/18800,0.007352039,0.032745146,0.015355017,PPP3CB/GPER1,2
GO:0051283,BP,GO:0051283,negative regulation of sequestering of calcium ion,2月20日,122/18800,0.007352039,0.032745146,0.015355017,GPER1/ITPR1,2
GO:0001781,BP,GO:0001781,neutrophil apoptotic process,1月20日,7/18800,0.007424265,0.032745146,0.015355017,ITPKB,1
GO:0003062,BP,GO:0003062,regulation of heart rate by chemical signal,1月20日,7/18800,0.007424265,0.032745146,0.015355017,YWHAE,1
GO:0007221,BP,GO:0007221,positive regulation of transcription of Notch receptor target,1月20日,7/18800,0.007424265,0.032745146,0.015355017,NOTCH1,1
GO:0016240,BP,GO:0016240,autophagosome membrane docking,1月20日,7/18800,0.007424265,0.032745146,0.015355017,ATP2A2,1
GO:0035726,BP,GO:0035726,common myeloid progenitor cell proliferation,1月20日,7/18800,0.007424265,0.032745146,0.015355017,ITPKB,1
GO:0044341,BP,GO:0044341,sodium-dependent phosphate transport,1月20日,7/18800,0.007424265,0.032745146,0.015355017,ATF4,1
GO:0044691,BP,GO:0044691,tooth eruption,1月20日,7/18800,0.007424265,0.032745146,0.015355017,SNX10,1
GO:0046532,BP,GO:0046532,regulation of photoreceptor cell differentiation,1月20日,7/18800,0.007424265,0.032745146,0.015355017,NOTCH1,1
GO:0050882,BP,GO:0050882,voluntary musculoskeletal movement,1月20日,7/18800,0.007424265,0.032745146,0.015355017,ITPR1,1
GO:0072007,BP,GO:0072007,mesangial cell differentiation,1月20日,7/18800,0.007424265,0.032745146,0.015355017,NOTCH1,1
GO:0086036,BP,GO:0086036,regulation of cardiac muscle cell membrane potential,1月20日,7/18800,0.007424265,0.032745146,0.015355017,ATP2A2,1
GO:0090649,BP,GO:0090649,response to oxygen-glucose deprivation,1月20日,7/18800,0.007424265,0.032745146,0.015355017,ATF4,1
GO:1903147,BP,GO:1903147,negative regulation of autophagy of mitochondrion,1月20日,7/18800,0.007424265,0.032745146,0.015355017,TSPO,1
GO:1903288,BP,GO:1903288,positive regulation of potassium ion import across plasma membrane,1月20日,7/18800,0.007424265,0.032745146,0.015355017,ATP1B1,1
GO:1904180,BP,GO:1904180,negative regulation of membrane depolarization,1月20日,7/18800,0.007424265,0.032745146,0.015355017,FZD9,1
GO:1990456,BP,GO:1990456,mitochondrion-endoplasmic reticulum membrane tethering,1月20日,7/18800,0.007424265,0.032745146,0.015355017,ATP2A2,1
GO:2001027,BP,GO:2001027,negative regulation of endothelial cell chemotaxis,1月20日,7/18800,0.007424265,0.032745146,0.015355017,NOTCH1,1
GO:0051282,BP,GO:0051282,regulation of sequestering of calcium ion,2月20日,124/18800,0.007586431,0.03336255,0.015644533,GPER1/ITPR1,2
GO:0030099,BP,GO:0030099,myeloid cell differentiation,3月20日,391/18800,0.007824417,0.034308813,0.016088259,ITPKB/SNX10/TMEM178A,3
GO:0050714,BP,GO:0050714,positive regulation of protein secretion,2月20日,128/18800,0.008065304,0.035160051,0.016487426,PPP3CB/GPER1,2
GO:0051208,BP,GO:0051208,sequestering of calcium ion,2月20日,128/18800,0.008065304,0.035160051,0.016487426,GPER1/ITPR1,2
GO:0048565,BP,GO:0048565,digestive tract development,2月20日,130/18800,0.008309758,0.035331877,0.016567999,CCKBR/NOTCH1,2
GO:0003162,BP,GO:0003162,atrioventricular node development,1月20日,8/18800,0.00848059,0.035331877,0.016567999,NOTCH1,1
GO:0003190,BP,GO:0003190,atrioventricular valve formation,1月20日,8/18800,0.00848059,0.035331877,0.016567999,NOTCH1,1
GO:0003344,BP,GO:0003344,pericardium morphogenesis,1月20日,8/18800,0.00848059,0.035331877,0.016567999,NOTCH1,1
GO:0032959,BP,GO:0032959,inositol trisphosphate biosynthetic process,1月20日,8/18800,0.00848059,0.035331877,0.016567999,GPER1,1
GO:0045607,BP,GO:0045607,regulation of inner ear auditory receptor cell differentiation,1月20日,8/18800,0.00848059,0.035331877,0.016567999,NOTCH1,1
GO:0045631,BP,GO:0045631,regulation of mechanoreceptor differentiation,1月20日,8/18800,0.00848059,0.035331877,0.016567999,NOTCH1,1
GO:0045955,BP,GO:0045955,negative regulation of calcium ion-dependent exocytosis,1月20日,8/18800,0.00848059,0.035331877,0.016567999,NOTCH1,1
GO:0050774,BP,GO:0050774,negative regulation of dendrite morphogenesis,1月20日,8/18800,0.00848059,0.035331877,0.016567999,PPP3CA,1
GO:0051901,BP,GO:0051901,positive regulation of mitochondrial depolarization,1月20日,8/18800,0.00848059,0.035331877,0.016567999,TSPO,1
GO:0062043,BP,GO:0062043,positive regulation of cardiac epithelial to mesenchymal transition,1月20日,8/18800,0.00848059,0.035331877,0.016567999,NOTCH1,1
GO:0070474,BP,GO:0070474,positive regulation of uterine smooth muscle contraction,1月20日,8/18800,0.00848059,0.035331877,0.016567999,GPER1,1
GO:0098909,BP,GO:0098909,regulation of cardiac muscle cell action potential involved in regulation of contraction,1月20日,8/18800,0.00848059,0.035331877,0.016567999,ATP2A2,1
GO:1903044,BP,GO:1903044,protein localization to membrane raft,1月20日,8/18800,0.00848059,0.035331877,0.016567999,ATP1B1,1
GO:2000973,BP,GO:2000973,regulation of pro-B cell differentiation,1月20日,8/18800,0.00848059,0.035331877,0.016567999,NOTCH1,1
GO:2000980,BP,GO:2000980,regulation of inner ear receptor cell differentiation,1月20日,8/18800,0.00848059,0.035331877,0.016567999,NOTCH1,1
GO:0060537,BP,GO:0060537,muscle tissue development,3月20日,405/18800,0.0086156,0.0357952,0.016785263,XK/PPP3CA/NOTCH1,3
GO:0045667,BP,GO:0045667,regulation of osteoblast differentiation,2月20日,136/18800,0.009063022,0.037550371,0.017608307,NOTCH1/ATF4,2
GO:0007586,BP,GO:0007586,digestion,2月20日,137/18800,0.00919145,0.037642819,0.017651658,SNX10/CCKBR,2
GO:0060048,BP,GO:0060048,cardiac muscle contraction,2月20日,138/18800,0.009320698,0.037642819,0.017651658,ATP1B1/ATP2A2,2
GO:0003266,BP,GO:0003266,regulation of secondary heart field cardioblast proliferation,1月20日,9/18800,0.009535847,0.037642819,0.017651658,NOTCH1,1
GO:0010248,BP,GO:0010248,establishment or maintenance of transmembrane electrochemical gradient,1月20日,9/18800,0.009535847,0.037642819,0.017651658,ATP1B1,1
GO:0010615,BP,GO:0010615,positive regulation of cardiac muscle adaptation,1月20日,9/18800,0.009535847,0.037642819,0.017651658,PPP3CA,1
GO:0014012,BP,GO:0014012,peripheral nervous system axon regeneration,1月20日,9/18800,0.009535847,0.037642819,0.017651658,TSPO,1
GO:0033292,BP,GO:0033292,T-tubule organization,1月20日,9/18800,0.009535847,0.037642819,0.017651658,ATP2A2,1
GO:0048845,BP,GO:0048845,venous blood vessel morphogenesis,1月20日,9/18800,0.009535847,0.037642819,0.017651658,NOTCH1,1
GO:0060242,BP,GO:0060242,contact inhibition,1月20日,9/18800,0.009535847,0.037642819,0.017651658,TSPO,1
GO:0060525,BP,GO:0060525,prostate glandular acinus development,1月20日,9/18800,0.009535847,0.037642819,0.017651658,NOTCH1,1
GO:0060768,BP,GO:0060768,regulation of epithelial cell proliferation involved in prostate gland development,1月20日,9/18800,0.009535847,0.037642819,0.017651658,NOTCH1,1
GO:0060982,BP,GO:0060982,coronary artery morphogenesis,1月20日,9/18800,0.009535847,0.037642819,0.017651658,NOTCH1,1
GO:0062042,BP,GO:0062042,regulation of cardiac epithelial to mesenchymal transition,1月20日,9/18800,0.009535847,0.037642819,0.017651658,NOTCH1,1
GO:0071476,BP,GO:0071476,cellular hypotonic response,1月20日,9/18800,0.009535847,0.037642819,0.017651658,TSPO,1
GO:1903244,BP,GO:1903244,positive regulation of cardiac muscle hypertrophy in response to stress,1月20日,9/18800,0.009535847,0.037642819,0.017651658,PPP3CA,1
GO:1903286,BP,GO:1903286,regulation of potassium ion import,1月20日,9/18800,0.009535847,0.037642819,0.017651658,ATP1B1,1
GO:1904238,BP,GO:1904238,pericyte cell differentiation,1月20日,9/18800,0.009535847,0.037642819,0.017651658,NOTCH1,1
GO:1905461,BP,GO:1905461,positive regulation of vascular associated smooth muscle cell apoptotic process,1月20日,9/18800,0.009535847,0.037642819,0.017651658,ATF4,1
GO:1903305,BP,GO:1903305,regulation of regulated secretory pathway,2月20日,140/18800,0.009581646,0.037724594,0.017690004,ATP2A2/NOTCH1,2
GO:0016311,BP,GO:0016311,dephosphorylation,3月20日,422/18800,0.009638056,0.037847614,0.017747691,PPP3CB/PPP3CA/YWHAE,3
GO:0002683,BP,GO:0002683,negative regulation of immune system process,3月20日,425/18800,0.009825593,0.038462753,0.018036145,PPP3CB/GPER1/TMEM178A,3
GO:0055123,BP,GO:0055123,digestive system development,2月20日,142/18800,0.009845851,0.038462753,0.018036145,CCKBR/NOTCH1,2
GO:0061351,BP,GO:0061351,neural precursor cell proliferation,2月20日,143/18800,0.009979171,0.038565171,0.018084172,FZD9/NOTCH1,2
GO:1903531,BP,GO:1903531,negative regulation of secretion by cell,2月20日,143/18800,0.009979171,0.038565171,0.018084172,PPP3CA/NOTCH1,2
GO:0051592,BP,GO:0051592,response to calcium ion,2月20日,144/18800,0.010113301,0.038565171,0.018084172,PPP3CA/ITPKB,2
GO:0007409,BP,GO:0007409,axonogenesis,3月20日,430/18800,0.010142923,0.038565171,0.018084172,XK/PPP3CB/NOTCH1,3
GO:0048732,BP,GO:0048732,gland development,3月20日,431/18800,0.010207107,0.038565171,0.018084172,TSPO/CCKBR/NOTCH1,3
GO:0072594,BP,GO:0072594,establishment of protein localization to organelle,3月20日,431/18800,0.010207107,0.038565171,0.018084172,PPP3CA/TSPO/NOTCH1,3
GO:0007269,BP,GO:0007269,neurotransmitter secretion,2月20日,145/18800,0.010248238,0.038565171,0.018084172,GPER1/ATP2A2,2
GO:0099643,BP,GO:0099643,signal release from synapse,2月20日,145/18800,0.010248238,0.038565171,0.018084172,GPER1/ATP2A2,2
GO:1903131,BP,GO:1903131,mononuclear cell differentiation,3月20日,433/18800,0.010336192,0.038565171,0.018084172,PPP3CB/FZD9/ITPKB,3
GO:0062013,BP,GO:0062013,positive regulation of small molecule metabolic process,2月20日,146/18800,0.010383981,0.038565171,0.018084172,GPER1/PTH1R,2
GO:0106106,BP,GO:0106106,cold-induced thermogenesis,2月20日,146/18800,0.010383981,0.038565171,0.018084172,NOTCH1/ATF4,2
GO:0120161,BP,GO:0120161,regulation of cold-induced thermogenesis,2月20日,146/18800,0.010383981,0.038565171,0.018084172,NOTCH1/ATF4,2
GO:0001915,BP,GO:0001915,negative regulation of T cell mediated cytotoxicity,1月20日,10/18800,0.010590037,0.038565171,0.018084172,PPP3CB,1
GO:0003183,BP,GO:0003183,mitral valve morphogenesis,1月20日,10/18800,0.010590037,0.038565171,0.018084172,NOTCH1,1
GO:0003211,BP,GO:0003211,cardiac ventricle formation,1月20日,10/18800,0.010590037,0.038565171,0.018084172,NOTCH1,1
GO:0003330,BP,GO:0003330,regulation of extracellular matrix constituent secretion,1月20日,10/18800,0.010590037,0.038565171,0.018084172,NOTCH1,1
GO:0007440,BP,GO:0007440,foregut morphogenesis,1月20日,10/18800,0.010590037,0.038565171,0.018084172,NOTCH1,1
GO:0035562,BP,GO:0035562,negative regulation of chromatin binding,1月20日,10/18800,0.010590037,0.038565171,0.018084172,PPP3CA,1
GO:0042045,BP,GO:0042045,epithelial fluid transport,1月20日,10/18800,0.010590037,0.038565171,0.018084172,ITPR1,1
GO:0060245,BP,GO:0060245,detection of cell density,1月20日,10/18800,0.010590037,0.038565171,0.018084172,TSPO,1
GO:0060742,BP,GO:0060742,epithelial cell differentiation involved in prostate gland development,1月20日,10/18800,0.010590037,0.038565171,0.018084172,NOTCH1,1
GO:0060767,BP,GO:0060767,epithelial cell proliferation involved in prostate gland development,1月20日,10/18800,0.010590037,0.038565171,0.018084172,NOTCH1,1
GO:0070472,BP,GO:0070472,regulation of uterine smooth muscle contraction,1月20日,10/18800,0.010590037,0.038565171,0.018084172,GPER1,1
GO:0071340,BP,GO:0071340,skeletal muscle acetylcholine-gated channel clustering,1月20日,10/18800,0.010590037,0.038565171,0.018084172,FZD9,1
GO:0071389,BP,GO:0071389,cellular response to mineralocorticoid stimulus,1月20日,10/18800,0.010590037,0.038565171,0.018084172,GPER1,1
GO:1904181,BP,GO:1904181,positive regulation of membrane depolarization,1月20日,10/18800,0.010590037,0.038565171,0.018084172,TSPO,1
GO:1905456,BP,GO:1905456,regulation of lymphoid progenitor cell differentiation,1月20日,10/18800,0.010590037,0.038565171,0.018084172,NOTCH1,1
GO:2000048,BP,GO:2000048,negative regulation of cell-cell adhesion mediated by cadherin,1月20日,10/18800,0.010590037,0.038565171,0.018084172,NOTCH1,1
GO:1904064,BP,GO:1904064,positive regulation of cation transmembrane transport,2月20日,148/18800,0.010657878,0.038718474,0.018156059,ATP1B1/GPER1,2
GO:0010675,BP,GO:0010675,regulation of cellular carbohydrate metabolic process,2月20日,150/18800,0.010934979,0.039629417,0.018583223,GPER1/PTH1R,2
GO:0036294,BP,GO:0036294,cellular response to decreased oxygen levels,2月20日,151/18800,0.011074726,0.039708195,0.018620164,NOTCH1/ATF4,2
GO:1903829,BP,GO:1903829,positive regulation of protein localization,3月20日,446/18800,0.011198709,0.039708195,0.018620164,PPP3CB/YWHAE/GPER1,3
GO:0035051,BP,GO:0035051,cardiocyte differentiation,2月20日,153/18800,0.011356607,0.039708195,0.018620164,GPER1/NOTCH1,2
GO:0051147,BP,GO:0051147,regulation of muscle cell differentiation,2月20日,153/18800,0.011356607,0.039708195,0.018620164,GPER1/NOTCH1,2
GO:0097553,BP,GO:0097553,calcium ion transmembrane import into cytosol,2月20日,154/18800,0.011498737,0.039708195,0.018620164,GPER1/ITPR1,2
GO:0007189,BP,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,2月20日,155/18800,0.011641659,0.039708195,0.018620164,GPER1/PTH1R,2
GO:0043271,BP,GO:0043271,negative regulation of ion transport,2月20日,155/18800,0.011641659,0.039708195,0.018620164,YWHAE/ATF4,2
GO:0003174,BP,GO:0003174,mitral valve development,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:0003263,BP,GO:0003263,cardioblast proliferation,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:0003264,BP,GO:0003264,regulation of cardioblast proliferation,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:0006971,BP,GO:0006971,hypotonic response,1月20日,11/18800,0.011643161,0.039708195,0.018620164,TSPO,1
GO:0031987,BP,GO:0031987,locomotion involved in locomotory behavior,1月20日,11/18800,0.011643161,0.039708195,0.018620164,PPP3CB,1
GO:0043619,BP,GO:0043619,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,1月20日,11/18800,0.011643161,0.039708195,0.018620164,ATF4,1
GO:0048103,BP,GO:0048103,somatic stem cell division,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:0060837,BP,GO:0060837,blood vessel endothelial cell differentiation,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:0061314,BP,GO:0061314,Notch signaling involved in heart development,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:0070471,BP,GO:0070471,uterine smooth muscle contraction,1月20日,11/18800,0.011643161,0.039708195,0.018620164,GPER1,1
GO:0072017,BP,GO:0072017,distal tubule development,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:0097084,BP,GO:0097084,vascular associated smooth muscle cell development,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:0097396,BP,GO:0097396,response to interleukin-17,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:0097398,BP,GO:0097398,cellular response to interleukin-17,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:0097400,BP,GO:0097400,interleukin-17-mediated signaling pathway,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:1901533,BP,GO:1901533,negative regulation of hematopoietic progenitor cell differentiation,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:1903799,BP,GO:1903799,negative regulation of production of miRNAs involved in gene silencing by miRNA,1月20日,11/18800,0.011643161,0.039708195,0.018620164,PPP3CA,1
GO:1905651,BP,GO:1905651,regulation of artery morphogenesis,1月20日,11/18800,0.011643161,0.039708195,0.018620164,NOTCH1,1
GO:1990440,BP,GO:1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,1月20日,11/18800,0.011643161,0.039708195,0.018620164,ATF4,1
GO:0031960,BP,GO:0031960,response to corticosteroid,2月20日,157/18800,0.011929866,0.0405023,0.01899254,GPER1/NOTCH1,2
GO:0055067,BP,GO:0055067,monovalent inorganic cation homeostasis,2月20日,157/18800,0.011929866,0.0405023,0.01899254,ATP1B1/CCKBR,2
GO:0022411,BP,GO:0022411,cellular component disassembly,3月20日,460/18800,0.012173378,0.041212358,0.019325504,TSPO/GPER1/ATP2A2,3
GO:0006606,BP,GO:0006606,protein import into nucleus,2月20日,159/18800,0.012221218,0.041212358,0.019325504,PPP3CA/NOTCH1,2
GO:1990845,BP,GO:1990845,adaptive thermogenesis,2月20日,159/18800,0.012221218,0.041212358,0.019325504,NOTCH1/ATF4,2
GO:0002328,BP,GO:0002328,pro-B cell differentiation,1月20日,12/18800,0.01269522,0.04196398,0.019677958,NOTCH1,1
GO:0003157,BP,GO:0003157,endocardium development,1月20日,12/18800,0.01269522,0.04196398,0.019677958,NOTCH1,1
GO:0048715,BP,GO:0048715,negative regulation of oligodendrocyte differentiation,1月20日,12/18800,0.01269522,0.04196398,0.019677958,NOTCH1,1
GO:0071372,BP,GO:0071372,cellular response to follicle-stimulating hormone stimulus,1月20日,12/18800,0.01269522,0.04196398,0.019677958,NOTCH1,1
GO:1901029,BP,GO:1901029,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,1月20日,12/18800,0.01269522,0.04196398,0.019677958,FZD9,1
GO:1902337,BP,GO:1902337,regulation of apoptotic process involved in morphogenesis,1月20日,12/18800,0.01269522,0.04196398,0.019677958,NOTCH1,1
GO:1903909,BP,GO:1903909,regulation of receptor clustering,1月20日,12/18800,0.01269522,0.04196398,0.019677958,FZD9,1
GO:1905205,BP,GO:1905205,positive regulation of connective tissue replacement,1月20日,12/18800,0.01269522,0.04196398,0.019677958,PPP3CA,1
GO:1990253,BP,GO:1990253,cellular response to leucine starvation,1月20日,12/18800,0.01269522,0.04196398,0.019677958,ATF4,1
GO:0007568,BP,GO:0007568,aging,2月20日,163/18800,0.012813298,0.042076855,0.019730888,PPP3CA/TSPO,2
GO:0034767,BP,GO:0034767,positive regulation of ion transmembrane transport,2月20日,163/18800,0.012813298,0.042076855,0.019730888,ATP1B1/GPER1,2
GO:0051170,BP,GO:0051170,import into nucleus,2月20日,163/18800,0.012813298,0.042076855,0.019730888,PPP3CA/NOTCH1,2
GO:0051100,BP,GO:0051100,negative regulation of binding,2月20日,165/18800,0.013114,0.042970492,0.020149937,PPP3CA/ATP2A2,2
GO:0071453,BP,GO:0071453,cellular response to oxygen levels,2月20日,166/18800,0.013265511,0.043372453,0.020338426,NOTCH1/ATF4,2
GO:0034765,BP,GO:0034765,regulation of ion transmembrane transport,3月20日,476/18800,0.013346021,0.04354103,0.020417476,YWHAE/ATP1B1/GPER1,3
GO:0051048,BP,GO:0051048,negative regulation of secretion,2月20日,167/18800,0.013417793,0.043680433,0.020482846,PPP3CA/NOTCH1,2
GO:0010960,BP,GO:0010960,magnesium ion homeostasis,1月20日,13/18800,0.013746215,0.043708895,0.020496193,XK,1
GO:0032536,BP,GO:0032536,regulation of cell projection size,1月20日,13/18800,0.013746215,0.043708895,0.020496193,XK,1
GO:0045605,BP,GO:0045605,negative regulation of epidermal cell differentiation,1月20日,13/18800,0.013746215,0.043708895,0.020496193,NOTCH1,1
GO:0045683,BP,GO:0045683,negative regulation of epidermis development,1月20日,13/18800,0.013746215,0.043708895,0.020496193,NOTCH1,1
GO:0048711,BP,GO:0048711,positive regulation of astrocyte differentiation,1月20日,13/18800,0.013746215,0.043708895,0.020496193,NOTCH1,1
GO:0061418,BP,GO:0061418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,1月20日,13/18800,0.013746215,0.043708895,0.020496193,NOTCH1,1
GO:0071287,BP,GO:0071287,cellular response to manganese ion,1月20日,13/18800,0.013746215,0.043708895,0.020496193,ATF4,1
GO:1900121,BP,GO:1900121,negative regulation of receptor binding,1月20日,13/18800,0.013746215,0.043708895,0.020496193,ATP2A2,1
GO:1900242,BP,GO:1900242,regulation of synaptic vesicle endocytosis,1月20日,13/18800,0.013746215,0.043708895,0.020496193,PPP3CB,1
GO:1903054,BP,GO:1903054,negative regulation of extracellular matrix organization,1月20日,13/18800,0.013746215,0.043708895,0.020496193,NOTCH1,1
GO:1904748,BP,GO:1904748,regulation of apoptotic process involved in development,1月20日,13/18800,0.013746215,0.043708895,0.020496193,NOTCH1,1
GO:0060402,BP,GO:0060402,calcium ion transport into cytosol,2月20日,171/18800,0.014034598,0.044531719,0.020882035,GPER1/ITPR1,2
GO:1905475,BP,GO:1905475,regulation of protein localization to membrane,2月20日,172/18800,0.01419071,0.044932269,0.021069863,FZD9/GPER1,2
GO:0046890,BP,GO:0046890,regulation of lipid biosynthetic process,2月20日,175/18800,0.014663608,0.045415113,0.021296281,TSPO/GPER1,2
GO:0003188,BP,GO:0003188,heart valve formation,1月20日,14/18800,0.014796147,0.045415113,0.021296281,NOTCH1,1
GO:0003207,BP,GO:0003207,cardiac chamber formation,1月20日,14/18800,0.014796147,0.045415113,0.021296281,NOTCH1,1
GO:0003222,BP,GO:0003222,ventricular trabecula myocardium morphogenesis,1月20日,14/18800,0.014796147,0.045415113,0.021296281,NOTCH1,1
GO:0014744,BP,GO:0014744,positive regulation of muscle adaptation,1月20日,14/18800,0.014796147,0.045415113,0.021296281,PPP3CA,1
GO:0030007,BP,GO:0030007,cellular potassium ion homeostasis,1月20日,14/18800,0.014796147,0.045415113,0.021296281,ATP1B1,1
GO:0033033,BP,GO:0033033,negative regulation of myeloid cell apoptotic process,1月20日,14/18800,0.014796147,0.045415113,0.021296281,ITPKB,1
GO:0035630,BP,GO:0035630,bone mineralization involved in bone maturation,1月20日,14/18800,0.014796147,0.045415113,0.021296281,SNX10,1
GO:0045059,BP,GO:0045059,positive thymic T cell selection,1月20日,14/18800,0.014796147,0.045415113,0.021296281,ITPKB,1
GO:0070278,BP,GO:0070278,extracellular matrix constituent secretion,1月20日,14/18800,0.014796147,0.045415113,0.021296281,NOTCH1,1
GO:0070307,BP,GO:0070307,lens fiber cell development,1月20日,14/18800,0.014796147,0.045415113,0.021296281,ATF4,1
GO:0070986,BP,GO:0070986,left/right axis specification,1月20日,14/18800,0.014796147,0.045415113,0.021296281,NOTCH1,1
GO:0099170,BP,GO:0099170,postsynaptic modulation of chemical synaptic transmission,1月20日,14/18800,0.014796147,0.045415113,0.021296281,PPP3CA,1
GO:1905065,BP,GO:1905065,positive regulation of vascular associated smooth muscle cell differentiation,1月20日,14/18800,0.014796147,0.045415113,0.021296281,GPER1,1
GO:1905203,BP,GO:1905203,regulation of connective tissue replacement,1月20日,14/18800,0.014796147,0.045415113,0.021296281,PPP3CA,1
GO:0001659,BP,GO:0001659,temperature homeostasis,2月20日,177/18800,0.014982657,0.045893924,0.021520807,NOTCH1/ATF4,2
GO:0006941,BP,GO:0006941,striated muscle contraction,2月20日,178/18800,0.015143313,0.046291753,0.021707359,ATP1B1/ATP2A2,2
GO:0006839,BP,GO:0006839,mitochondrial transport,2月20日,182/18800,0.015793433,0.047471925,0.022260771,TSPO/FZD9,2
GO:0015698,BP,GO:0015698,inorganic anion transport,2月20日,182/18800,0.015793433,0.047471925,0.022260771,TSPO/ATF4,2
GO:0003214,BP,GO:0003214,cardiac left ventricle morphogenesis,1月20日,15/18800,0.015845018,0.047471925,0.022260771,NOTCH1,1
GO:0010832,BP,GO:0010832,negative regulation of myotube differentiation,1月20日,15/18800,0.015845018,0.047471925,0.022260771,NOTCH1,1
GO:0036376,BP,GO:0036376,sodium ion export across plasma membrane,1月20日,15/18800,0.015845018,0.047471925,0.022260771,ATP1B1,1
GO:0060354,BP,GO:0060354,negative regulation of cell adhesion molecule production,1月20日,15/18800,0.015845018,0.047471925,0.022260771,NOTCH1,1
GO:0072044,BP,GO:0072044,collecting duct development,1月20日,15/18800,0.015845018,0.047471925,0.022260771,NOTCH1,1
GO:0099509,BP,GO:0099509,regulation of presynaptic cytosolic calcium ion concentration,1月20日,15/18800,0.015845018,0.047471925,0.022260771,ATP2B3,1
GO:1905288,BP,GO:1905288,vascular associated smooth muscle cell apoptotic process,1月20日,15/18800,0.015845018,0.047471925,0.022260771,ATF4,1
GO:1905459,BP,GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,1月20日,15/18800,0.015845018,0.047471925,0.022260771,ATF4,1
GO:0006109,BP,GO:0006109,regulation of carbohydrate metabolic process,2月20日,183/18800,0.015957829,0.047620189,0.022330296,GPER1/PTH1R,2
GO:0099504,BP,GO:0099504,synaptic vesicle cycle,2月20日,183/18800,0.015957829,0.047620189,0.022330296,PPP3CB/ATP2A2,2
GO:0046578,BP,GO:0046578,regulation of Ras protein signal transduction,2月20日,187/18800,0.016622835,0.049506422,0.023214798,ITPKB/NOTCH1,2
GO:0001780,BP,GO:0001780,neutrophil homeostasis,1月20日,16/18800,0.016892827,0.049622679,0.023269313,ITPKB,1
GO:0034393,BP,GO:0034393,positive regulation of smooth muscle cell apoptotic process,1月20日,16/18800,0.016892827,0.049622679,0.023269313,ATF4,1
GO:0048266,BP,GO:0048266,behavioral response to pain,1月20日,16/18800,0.016892827,0.049622679,0.023269313,TSPO,1
GO:0060841,BP,GO:0060841,venous blood vessel development,1月20日,16/18800,0.016892827,0.049622679,0.023269313,NOTCH1,1
GO:0072109,BP,GO:0072109,glomerular mesangium development,1月20日,16/18800,0.016892827,0.049622679,0.023269313,NOTCH1,1
GO:1901201,BP,GO:1901201,regulation of extracellular matrix assembly,1月20日,16/18800,0.016892827,0.049622679,0.023269313,NOTCH1,1
GO:2000651,BP,GO:2000651,positive regulation of sodium ion transmembrane transporter activity,1月20日,16/18800,0.016892827,0.049622679,0.023269313,ATP1B1,1
GO:0005955,CC,GO:0005955,calcineurin complex,3月20日,5/19594,9.08E-09,1.06E-06,5.45E-07,PPP3CB/PPP3CA/ITPR1,3
GO:0005963,CC,GO:0005963,magnesium-dependent protein serine/threonine phosphatase complex,3月20日,28/19594,2.93E-06,0.000171469,8.79E-05,PPP3CB/PPP3CA/ITPR1,3
GO:0008287,CC,GO:0008287,protein serine/threonine phosphatase complex,3月20日,50/19594,1.73E-05,0.000505647,0.000259306,PPP3CB/PPP3CA/ITPR1,3
GO:1903293,CC,GO:1903293,phosphatase complex,3月20日,50/19594,1.73E-05,0.000505647,0.000259306,PPP3CB/PPP3CA/ITPR1,3
GO:0031095,CC,GO:0031095,platelet dense tubular network membrane,2月20日,9/19594,3.55E-05,0.000830263,0.000425776,ITPR1/ATP2A2,2
GO:0031094,CC,GO:0031094,platelet dense tubular network,2月20日,11/19594,5.41E-05,0.001055753,0.000541412,ITPR1/ATP2A2,2
GO:0098978,CC,GO:0098978,glutamatergic synapse,4月20日,319/19594,0.000271818,0.004480426,0.002297654,PPP3CB/PPP3CA/FZD9/ATP2B3,4
GO:0042383,CC,GO:0042383,sarcolemma,3月20日,131/19594,0.000306354,0.004480426,0.002297654,PPP3CB/PPP3CA/ATP1B1,3
GO:0032590,CC,GO:0032590,dendrite membrane,2月20日,41/19594,0.000792508,0.009307659,0.004773158,GPER1/ATF4,2
GO:0045177,CC,GO:0045177,apical part of cell,4月20日,424/19594,0.000795526,0.009307659,0.004773158,ATP1B1/SNX10/PTH1R/NOTCH1,4
GO:0030315,CC,GO:0030315,T-tubule,2月20日,51/19594,0.001224739,0.013026774,0.006680397,PPP3CB/ATP1B1,2
GO:0032589,CC,GO:0032589,neuron projection membrane,2月20日,58/19594,0.001581057,0.015415306,0.007905285,GPER1/ATF4,2
GO:1990032,CC,GO:1990032,parallel fiber,1月20日,2/19594,0.002040451,0.015915521,0.008161806,ATP2B3,1
GO:1990590,CC,GO:1990590,ATF1-ATF4 transcription factor complex,1月20日,2/19594,0.002040451,0.015915521,0.008161806,ATF4,1
GO:1990617,CC,GO:1990617,CHOP-ATF4 complex,1月20日,2/19594,0.002040451,0.015915521,0.008161806,ATF4,1
GO:0016529,CC,GO:0016529,sarcoplasmic reticulum,2月20日,71/19594,0.002358035,0.016682317,0.008555034,ITPR1/ATP2A2,2
GO:0098685,CC,GO:0098685,Schaffer collateral - CA1 synapse,2月20日,72/19594,0.002423926,0.016682317,0.008555034,PPP3CA/ITPR1,2
GO:0016528,CC,GO:0016528,sarcoplasm,2月20日,78/19594,0.002837409,0.017044077,0.008740552,ITPR1/ATP2A2,2
GO:0002193,CC,GO:0002193,MAML1-RBP-Jkappa- ICN1 complex,1月20日,3/19594,0.003059193,0.017044077,0.008740552,NOTCH1,1
GO:0090651,CC,GO:0090651,apical cytoplasm,1月20日,3/19594,0.003059193,0.017044077,0.008740552,SNX10,1
GO:1990037,CC,GO:1990037,Lewy body core,1月20日,3/19594,0.003059193,0.017044077,0.008740552,ATF4,1
GO:1990589,CC,GO:1990589,ATF4-CREB1 transcription factor complex,1月20日,4/19594,0.004076947,0.021681946,0.011118947,ATF4,1
GO:0031253,CC,GO:0031253,cell projection membrane,3月20日,339/19594,0.004703399,0.023925988,0.012269737,FZD9/GPER1/ATF4,3
GO:0016324,CC,GO:0016324,apical plasma membrane,3月20日,358/19594,0.005473983,0.026685669,0.013684959,ATP1B1/PTH1R/NOTCH1,3
GO:0031088,CC,GO:0031088,platelet dense granule membrane,1月20日,6/19594,0.006109495,0.028592434,0.014662787,ITPR1,1
GO:0044327,CC,GO:0044327,dendritic spine head,1月20日,7/19594,0.00712429,0.031738593,0.016276201,GPER1,1
GO:0030018,CC,GO:0030018,Z disc,2月20日,127/19594,0.007337093,0.031738593,0.016276201,PPP3CB/PPP3CA,2
GO:0036056,CC,GO:0036056,filtration diaphragm,1月20日,8/19594,0.008138101,0.031738593,0.016276201,PPP3CA,1
GO:0036057,CC,GO:0036057,slit diaphragm,1月20日,8/19594,0.008138101,0.031738593,0.016276201,PPP3CA,1
GO:0097413,CC,GO:0097413,Lewy body,1月20日,8/19594,0.008138101,0.031738593,0.016276201,ATF4,1
GO:0031674,CC,GO:0031674,I band,2月20日,139/19594,0.008731064,0.032952727,0.016898834,PPP3CB/PPP3CA,2
GO:0042734,CC,GO:0042734,presynaptic membrane,2月20日,143/19594,0.009220176,0.033711268,0.01728783,GPER1/ATP2B3,2
GO:0031313,CC,GO:0031313,extrinsic component of endosome membrane,1月20日,10/19594,0.010162773,0.034971895,0.017934305,SNX10,1
GO:0097470,CC,GO:0097470,ribbon synapse,1月20日,10/19594,0.010162773,0.034971895,0.017934305,ATP2A2,1
GO:0005890,CC,GO:0005890,sodium:potassium-exchanging ATPase complex,1月20日,12/19594,0.012183519,0.040678216,0.020860624,ATP1B1,1
GO:0043197,CC,GO:0043197,dendritic spine,2月20日,172/19594,0.013121113,0.040678216,0.020860624,PPP3CA/GPER1,2
GO:0044309,CC,GO:0044309,neuron spine,2月20日,173/19594,0.013266501,0.040678216,0.020860624,PPP3CA/GPER1,2
GO:0005911,CC,GO:0005911,cell-cell junction,3月20日,497/19594,0.013413183,0.040678216,0.020860624,PPP3CA/ATP1B1/NOTCH1,3
GO:0031256,CC,GO:0031256,leading edge membrane,2月20日,175/19594,0.013559405,0.040678216,0.020860624,GPER1/ATF4,2
GO:0032591,CC,GO:0032591,dendritic spine membrane,1月20日,15/19594,0.01520729,0.043396414,0.022254571,GPER1,1
GO:0098688,CC,GO:0098688,parallel fiber to Purkinje cell synapse,1月20日,15/19594,0.01520729,0.043396414,0.022254571,ATP2B3,1
GO:0031527,CC,GO:0031527,filopodium membrane,1月20日,18/19594,0.018222267,0.049581518,0.02542642,FZD9,1
GO:0090533,CC,GO:0090533,cation-transporting ATPase complex,1月20日,18/19594,0.018222267,0.049581518,0.02542642,ATP1B1,1
GO:0015662,MF,GO:0015662,P-type ion transporter activity,3月19日,20/18410,1.05E-06,6.83E-05,2.54E-05,ATP1B1/ATP2B3/ATP2A2,3
GO:0140358,MF,GO:0140358,P-type transmembrane transporter activity,3月19日,20/18410,1.05E-06,6.83E-05,2.54E-05,ATP1B1/ATP2B3/ATP2A2,3
GO:0042562,MF,GO:0042562,hormone binding,4月19日,87/18410,1.71E-06,7.40E-05,2.76E-05,TSPO/GPER1/CCKBR/PTH1R,4
GO:0044325,MF,GO:0044325,transmembrane transporter binding,4月19日,127/18410,7.73E-06,0.000251087,9.35E-05,TSPO/YWHAE/GRINA/ATP2A2,4
GO:0033192,MF,GO:0033192,calmodulin-dependent protein phosphatase activity,2月19日,5/18410,1.01E-05,0.000260366,9.70E-05,PPP3CB/PPP3CA,2
GO:0019829,MF,GO:0019829,ATPase-coupled cation transmembrane transporter activity,3月19日,44/18410,1.20E-05,0.000260366,9.70E-05,ATP1B1/ATP2B3/ATP2A2,3
GO:0004723,MF,GO:0004723,calcium-dependent protein serine/threonine phosphatase activity,2月19日,7/18410,2.11E-05,0.000392346,0.000146137,PPP3CB/PPP3CA,2
GO:0005388,MF,GO:0005388,P-type calcium transporter activity,2月19日,9/18410,3.62E-05,0.000587795,0.000218936,ATP2B3/ATP2A2,2
GO:0005516,MF,GO:0005516,calmodulin binding,4月19日,200/18410,4.61E-05,0.00066591,0.000248031,PPP3CB/PPP3CA/ITPKB/ATP2B3,4
GO:0051117,MF,GO:0051117,ATPase binding,3月19日,82/18410,7.84E-05,0.00101904,0.000379562,PPP3CA/ATP1B1/SNX10,3
GO:0042626,MF,GO:0042626,ATPase-coupled transmembrane transporter activity,3月19日,90/18410,0.000103445,0.001222529,0.000455355,ATP1B1/ATP2B3/ATP2A2,3
GO:0046982,MF,GO:0046982,protein heterodimerization activity,4月19日,332/18410,0.000324953,0.003238775,0.001206345,YWHAE/ATP1B1/FZD9/ATF4,4
GO:0015085,MF,GO:0015085,calcium ion transmembrane transporter activity,3月19日,135/18410,0.000342878,0.003238775,0.001206345,ITPR1/ATP2B3/ATP2A2,3
GO:0023026,MF,GO:0023026,MHC class II protein complex binding,2月19日,27/18410,0.000348791,0.003238775,0.001206345,YWHAE/ATP1B1,2
GO:0015399,MF,GO:0015399,primary active transmembrane transporter activity,3月19日,162/18410,0.000584338,0.005058452,0.00188412,ATP1B1/ATP2B3/ATP2A2,3
GO:0023023,MF,GO:0023023,MHC protein complex binding,2月19日,36/18410,0.000622579,0.005058452,0.00188412,YWHAE/ATP1B1,2
GO:0046873,MF,GO:0046873,metal ion transmembrane transporter activity,4月19日,428/18410,0.000846157,0.005833314,0.002172732,ATP1B1/ITPR1/ATP2B3/ATP2A2,4
GO:0005246,MF,GO:0005246,calcium channel regulator activity,2月19日,43/18410,0.000888529,0.005833314,0.002172732,YWHAE/ITPR1,2
GO:0015054,MF,GO:0015054,gastrin receptor activity,1月19日,1/18410,0.001032048,0.005833314,0.002172732,CCKBR,1
GO:0031739,MF,GO:0031739,cholecystokinin receptor binding,1月19日,1/18410,0.001032048,0.005833314,0.002172732,CCKBR,1
GO:0031741,MF,GO:0031741,type B gastrin/cholecystokinin receptor binding,1月19日,1/18410,0.001032048,0.005833314,0.002172732,CCKBR,1
GO:0086039,MF,GO:0086039,P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential,1月19日,1/18410,0.001032048,0.005833314,0.002172732,ATP2A2,1
GO:0098695,MF,GO:0098695,"inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels",1月19日,1/18410,0.001032048,0.005833314,0.002172732,ITPR1,1
GO:0017046,MF,GO:0017046,peptide hormone binding,2月19日,52/18410,0.001297551,0.007028399,0.002617865,CCKBR/PTH1R,2
GO:0004951,MF,GO:0004951,cholecystokinin receptor activity,1月19日,2/18410,0.002063086,0.010282258,0.003829829,CCKBR,1
GO:0004991,MF,GO:0004991,parathyroid hormone receptor activity,1月19日,2/18410,0.002063086,0.010282258,0.003829829,PTH1R,1
GO:0022853,MF,GO:0022853,active ion transmembrane transporter activity,3月19日,254/18410,0.002135546,0.010282258,0.003829829,ATP1B1/ATP2B3/ATP2A2,3
GO:0005220,MF,GO:0005220,"inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",1月19日,3/18410,0.003093117,0.013403507,0.004992399,ITPR1,1
GO:0030284,MF,GO:0030284,nuclear estrogen receptor activity,1月19日,3/18410,0.003093117,0.013403507,0.004992399,GPER1,1
GO:1905056,MF,GO:1905056,P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration,1月19日,3/18410,0.003093117,0.013403507,0.004992399,ATP2B3,1
GO:0043178,MF,GO:0043178,alcohol binding,2月19日,89/18410,0.003745865,0.015708467,0.005850927,TSPO/ITPR1,2
GO:0005497,MF,GO:0005497,androgen binding,1月19日,4/18410,0.00412214,0.01595439,0.005942526,TSPO,1
GO:0008440,MF,GO:0008440,"inositol-1,4,5-trisphosphate 3-kinase activity",1月19日,4/18410,0.00412214,0.01595439,0.005942526,ITPKB,1
GO:0042277,MF,GO:0042277,peptide binding,3月19日,322/18410,0.004172687,0.01595439,0.005942526,PPP3CA/CCKBR/PTH1R,3
GO:0004722,MF,GO:0004722,protein serine/threonine phosphatase activity,2月19日,100/18410,0.004703083,0.016983354,0.006325784,PPP3CB/PPP3CA,2
GO:0005496,MF,GO:0005496,steroid binding,2月19日,100/18410,0.004703083,0.016983354,0.006325784,TSPO/GPER1,2
GO:0051766,MF,GO:0051766,inositol trisphosphate kinase activity,1月19日,5/18410,0.005150157,0.018095147,0.006739893,ITPKB,1
GO:1990239,MF,GO:1990239,steroid hormone binding,1月19日,6/18410,0.006177169,0.021132419,0.007871184,GPER1,1
GO:0005391,MF,GO:0005391,P-type sodium:potassium-exchanging transporter activity,1月19日,7/18410,0.007203176,0.022839338,0.00850696,ATP1B1,1
GO:0008554,MF,GO:0008554,P-type sodium transporter activity,1月19日,7/18410,0.007203176,0.022839338,0.00850696,ATP1B1,1
GO:0030346,MF,GO:0030346,protein phosphatase 2B binding,1月19日,7/18410,0.007203176,0.022839338,0.00850696,PPP3CB,1
GO:0033218,MF,GO:0033218,amide binding,3月19日,402/18410,0.007721397,0.023663935,0.008814097,PPP3CA/CCKBR/PTH1R,3
GO:0022804,MF,GO:0022804,active transmembrane transporter activity,3月19日,404/18410,0.007827302,0.023663935,0.008814097,ATP1B1/ATP2B3/ATP2A2,3
GO:0000828,MF,GO:0000828,inositol hexakisphosphate kinase activity,1月19日,8/18410,0.008228179,0.023770296,0.008853713,ITPKB,1
GO:0008556,MF,GO:0008556,P-type potassium transmembrane transporter activity,1月19日,8/18410,0.008228179,0.023770296,0.008853713,ATP1B1,1
GO:0099106,MF,GO:0099106,ion channel regulator activity,2月19日,138/18410,0.008774609,0.024797808,0.00923643,YWHAE/ITPR1,2
GO:0008140,MF,GO:0008140,cAMP response element binding protein binding,1月19日,9/18410,0.00925218,0.024926965,0.009284537,ATF4,1
GO:0050815,MF,GO:0050815,phosphoserine residue binding,1月19日,9/18410,0.00925218,0.024926965,0.009284537,YWHAE,1
GO:0016247,MF,GO:0016247,channel regulator activity,2月19日,143/18410,0.009395548,0.024926965,0.009284537,YWHAE/ITPR1,2
GO:0008528,MF,GO:0008528,G protein-coupled peptide receptor activity,2月19日,148/18410,0.010035677,0.025581138,0.009528197,CCKBR/PTH1R,2
GO:0019903,MF,GO:0019903,protein phosphatase binding,2月19日,148/18410,0.010035677,0.025581138,0.009528197,PPP3CB/YWHAE,2
GO:0001653,MF,GO:0001653,peptide receptor activity,2月19日,154/18410,0.010828892,0.02670242,0.009945841,CCKBR/PTH1R,2
GO:0008503,MF,GO:0008503,benzodiazepine receptor activity,1月19日,11/18410,0.011297178,0.02670242,0.009945841,TSPO,1
GO:0019855,MF,GO:0019855,calcium channel inhibitor activity,1月19日,11/18410,0.011297178,0.02670242,0.009945841,ITPR1,1
GO:0043522,MF,GO:0043522,leucine zipper domain binding,1月19日,11/18410,0.011297178,0.02670242,0.009945841,ATF4,1
GO:0070679,MF,GO:0070679,"inositol 1,4,5 trisphosphate binding",1月19日,13/18410,0.013338176,0.030963623,0.011533009,ITPR1,1
GO:0004721,MF,GO:0004721,phosphoprotein phosphatase activity,2月19日,177/18410,0.014117057,0.031775417,0.011835378,PPP3CB/PPP3CA,2
GO:0044548,MF,GO:0044548,S100 protein binding,1月19日,14/18410,0.014357178,0.031775417,0.011835378,ATP2A2,1
GO:0008022,MF,GO:0008022,protein C-terminus binding,2月19日,179/18410,0.014421151,0.031775417,0.011835378,ATP1B1/ATF4,2
GO:0005545,MF,GO:0005545,1-phosphatidylinositol binding,1月19日,15/18410,0.015375182,0.032766782,0.012204631,SNX10,1
GO:0042813,MF,GO:0042813,Wnt-activated receptor activity,1月19日,15/18410,0.015375182,0.032766782,0.012204631,FZD9,1
GO:0030275,MF,GO:0030275,LRR domain binding,1月19日,16/18410,0.016392191,0.033777736,0.012581181,ATF4,1
GO:0046935,MF,GO:0046935,1-phosphatidylinositol-3-kinase regulator activity,1月19日,16/18410,0.016392191,0.033777736,0.012581181,CCKBR,1
GO:0019902,MF,GO:0019902,phosphatase binding,2月19日,193/18410,0.016629039,0.033777736,0.012581181,PPP3CB/YWHAE,2
GO:0015278,MF,GO:0015278,calcium-release channel activity,1月19日,17/18410,0.017408204,0.034816409,0.012968055,ITPR1,1
GO:0035014,MF,GO:0035014,phosphatidylinositol 3-kinase regulator activity,1月19日,19/18410,0.019437249,0.03828549,0.014260183,CCKBR,1
GO:0016018,MF,GO:0016018,cyclosporin A binding,1月19日,20/18410,0.020450282,0.039679652,0.014779465,PPP3CA,1
GO:0120020,MF,GO:0120020,cholesterol transfer activity,1月19日,22/18410,0.022473375,0.042963804,0.016002713,TSPO,1
GO:0120015,MF,GO:0120015,sterol transfer activity,1月19日,23/18410,0.023483436,0.044244154,0.016479604,TSPO,1
GO:0003707,MF,GO:0003707,nuclear steroid receptor activity,1月19日,24/18410,0.024492508,0.045486087,0.016942186,GPER1,1
GO:0005112,MF,GO:0005112,Notch binding,1月19日,25/18410,0.025500593,0.046691226,0.017391064,NOTCH1,1
GO:0001671,MF,GO:0001671,ATPase activator activity,1月19日,26/18410,0.02650769,0.047205476,0.017582606,ATP1B1,1
GO:0099604,MF,GO:0099604,ligand-gated calcium channel activity,1月19日,26/18410,0.02650769,0.047205476,0.017582606,ITPR1,1
